CBD #1

CBD #1 is a hybrid cannabis strain with up to 1.5% THC, known for its focused effects and earthy and herbal flavor profile.

CBD #1 is a cannabis strain specifically bred for its high cannabidiol (CBD) content and minimal tetrahydrocannabinol (THC) levels, making it one of the pioneering strains in the medical cannabis movement. Developed in the early 2000s by breeders seeking to create therapeutic cannabis options without significant psychoactive effects, CBD #1 emerged from selective breeding programs that focused on maximizing CBD expression while minimizing THC production. The strain's exact genetic origins are somewhat obscure in cannabis literature, but it is generally understood to be derived from hemp genetics crossed with traditional cannabis varieties that exhibited naturally higher CBD profiles.

The plant typically displays characteristics of both indica and sativa varieties, with medium-height plants featuring dense, resinous buds that often appear lighter green with occasional orange pistils. CBD #1 gained prominence as medical cannabis research expanded, particularly for patients seeking relief from various conditions without experiencing strong intoxication. Its development represented a significant shift in cannabis breeding priorities, moving beyond solely THC-focused strains to create varieties with specific cannabinoid ratios for therapeutic applications.

Notable features of CBD #1 include its consistent cannabinoid profile, with CBD levels typically ranging from 15-20% and THC content remaining below 1.5%, creating a CBD:THC ratio of approximately 20:1. This predictable chemical composition made it valuable for medical applications where dosage consistency is important. The strain's popularity helped establish CBD-dominant cannabis as a distinct category within the broader cannabis market, influencing subsequent breeding programs and consumer awareness about non-intoxicating cannabis options.